SELLAS Life Sciences Group
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.80-3.2824.421.25
Price/Sales ratio
0.841.650.300.17
Earnings per Share (EPS)
$-0.61$-0.52$0.07$1.36

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.92-3.57-0.82-0.76-0.58-0.57-2.76-4.13-1.12-0.78-0.45-0.58
Price/Sales ratio
19.34N/AN/AN/AN/AN/A24.3911.2645.77N/A30.45N/A
Price/Book Value ratio
4.8616.880.678.813.061.801.654.209.43-3.696.273.06
Price/Cash Flow ratio
-4.20-4.73-0.43-1.66-0.52-0.62-4.44-3.29-1.92-0.93-0.82-0.62
Price/Free Cash Flow ratio
-3.72-4.72-0.43-1.66-0.52-0.62-4.44-3.29-1.61-0.79-0.73-0.62
Price/Earnings Growth ratio
0.07-0.100.010.000.000.000.030.11-0.010.02-0.040.00
Dividend Yield
N/AN/AN/A3.69%3.02%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
84.94%N/AN/AN/AN/AN/A100%97.36%90%N/A80%N/A
Operating Profit Margin
-560.38%N/AN/AN/AN/AN/A-893.78%-332.81%-4195%N/A-6730.80%N/A
Pretax Profit Margin
-392.81%N/AN/AN/AN/AN/A-882.84%-275.47%-4130.1%N/A-6645.90%N/A
Net Profit Margin
-392.81%N/AN/AN/AN/AN/A-881.94%-272.35%-4065.20%N/A-6645.90%N/A
Effective Tax Rate
42.19%-0.94%-2.23%-1.07%4.74%0.41%0.10%1.13%1.57%N/AN/A0.41%
Return on Assets
-45.48%-77.79%-35.78%-70.85%-163.58%-116.15%-36.38%-78.77%-194.10%-600.41%-317.33%-116.15%
Return On Equity
-98.77%-472.89%-82.17%-1147.53%-527.55%-316.62%-59.92%-101.73%-838.01%468.15%-655.89%-316.62%
Return on Capital Employed
-98.06%-136.48%-89.98%-257.21%-284.15%-177.05%-50.37%-118.79%-772.84%503.84%-1240.01%-177.05%
Liquidity Ratios
Current Ratio
1.060.931.230.530.971.552.99N/AN/AN/A1.140.97
Quick Ratio
1.041.281.230.530.971.442.954.621.140.231.100.97
Cash ratio
0.860.520.590.090.891.372.864.281.100.181.100.89
Days of Sales Outstanding
72.02N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
170.40-20.05KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
242.43N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
590.811.64KN/AN/AN/AN/AN/A3.91K12.25KN/A6.12KN/A
Cash Conversion Cycle
-348.38N/AN/AN/AN/AN/AN/A-3.91K-12.25KN/A-6.12KN/A
Debt Ratios
Debt Ratio
0.100.050.110.32N/A0.010.000.000.01N/A0.760.76
Debt Equity Ratio
0.220.350.255.30N/A0.030.000.000.07N/A3.313.31
Long-term Debt to Capitalization
0.10N/A0.160.55N/AN/AN/AN/AN/AN/A0.10N/A
Total Debt to Capitalization
0.180.250.200.84N/A0.030.000.000.07N/A0.160.16
Interest Coverage Ratio
-47.04-45.02-9.08-45.79-116.87N/AN/AN/AN/AN/A-423.32N/A
Cash Flow to Debt Ratio
-5.10-10.16-6.09-1.00N/A-81.30-62.75-131.41-64.00N/A-38.85-38.85
Company Equity Multiplier
2.176.072.2916.193.222.721.641.294.31-0.774.313.22
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.60N/AN/AN/AN/AN/A-5.48-3.42-23.80N/A-36.72N/A
Free Cash Flow / Operating Cash Flow Ratio
1.121.001.00111111.181.171.121
Cash Flow Coverage Ratio
-5.10-10.16-6.09-1.00N/A-81.30-62.75-131.41-64.00N/A-38.85-38.85
Short Term Coverage Ratio
-10.96-10.16-26.28-1.31N/A-81.30-62.75-131.41-64.00N/A-98.70-81.30
Dividend Payout Ratio
N/AN/AN/A-2.84%-1.76%N/AN/AN/AN/AN/AN/A-1.76%